Health ❯ Diseases ❯ Blood Disorders

Sickle Cell Disease

Patient Experiences Gene Therapies Casgevy Cure Options Prevalence Treatment Future Treatments Access to Treatment Gene Therapy Lyfgenia Gene Editing Research and Development Causes Clinical Trials Genetics Treatment Options FDA Approval Symptoms Genetic Causes Impact on Black People Challenges in Developing Countries Genetic Factors Pain Management Patient Care CRISPR Gene Editing Cost of Treatment Treatment Development Stem Cell Transplant Global Impact Pain Crises Patient Demographics Severe Forms FDA Approvals Genetic Mutation Drug Approvals Hospitalization Statistics

NYU Study Finds Highest Sickle Cell Death Risk and Costs on Long Island

The findings point to gaps in specialist access on Long Island.

Agios’ Sickle Cell Pill Lifts Hemoglobin but Misses Pain-Crisis Goal in Phase 3